National HIV/AIDS Prevention Project

Abstract*

The National HIV/AIDS Prevention Project will assist the Government of Sri Lanka to curb the spread of HIV infection among its highly vulnerable subpopulations and the population at large, without stigmatizing those who are engaging in high risk behaviors. Furthermore, by acting now to revitalize and expand the tuberculosis control program, Sri Lanka can help reduce the risk of an emerging HIV-associated TB epidemic among the HIV-infected and the... Show More

Development Objective

To reduce the spread of HIV/AIDS among highly vulnerable subpopulations and the public at large.

Key Details

Project Details

Project ID
P074730
Status
Closed
Team Leader
Sandra Rosenhouse
Borrower 2
N/A

Country
Sri Lanka
Disclosure Date
November 27, 2001
Approval Date
(as of board presentation)
December 17, 2002
Effective Date
March 24, 2003

Total Project Cost 1
US$ 20.87 million
Implementing Agency
N/A
Region
South Asia
Fiscal Year 3
2003

Commitment Amount
US$ 18.96 million
Environmental Category
B
Environmental and Social Risk
Not Applicable
Closing Date
June 30, 2008

Last Stage Reached
BANK APPROVED
Last Update Date
January 15, 2013

Notes
1. Total project cost includes funding from World Bank and non-bank sources in US$ millions. Active and Closed projects show current commitments. Proposed (pipeline) and dropped projects show the forecast amount. The commitment amount for projects in the pipeline is indicative and may be modified during the project preparation.
2. Borrower refers to the Borrower of a Loan or Recipient of a Grant.
3. ”Fiscal Year” is the fiscal year in which the project was approved (or dropped if the status is dropped). The World Bank's fiscal year is from July 1 - June 30. For example, a fiscal year of 1996 corresponds to July 1, 1995 - June 30, 1996.

Sectors

Themes

FY17 - Human Development and Gender

FY17 - Disease Control45%
- FY17 - HIV/AIDS23%
- FY17 - Tuberculosis22%
FY17 - Gender11%

FY17 - Public Sector Management

FY17 - Public Administration22%
- FY17 - Transparency, Accountability and Good Governance22%

FY17 - Social Development and Protection

FY17 - Social Protection22%
- FY17 - Social protection delivery systems22%

Project Map

Interactive Map

Finances

Financing Plan (US$ Millions)

Financier	Commitments
Borrower/Recipient	1.91
The Global Fund to Fight AIDS, Tuberculosis & Malaria	6.36
IDA GRANT FOR HIV/AIDS	12.60

Total Project Financing (US$ Millions)

Product Line	IBRD/IDA
IBRD Commitment	N/A
IDA Commitment	12.60
IBRD + IDA Commitment	12.60

Lending Instrument
Grant Amount	6.36
Total Project Cost**	20.87

Summary Status of World Bank Financing (US$ Millions) as of July 31, 2025

No data available.

Detailed Financial Activity as of July 31, 2025

Download:

Period	Financier	Transaction Type	Amount (US$)
Dec 17, 2002	IDA-H0130	Loan Commitment	12,600,000.00

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name	Review	Date
Overall Safeguards Rating	Moderately Unsatisfactory	2008-06-26
Counterpart Funding	Moderately Unsatisfactory	2008-06-26
Progress towards achievement of PDO	Moderately Unsatisfactory	2008-06-26
Overall Implementation Progress (IP)	Unsatisfactory	2008-06-26
Procurement	Moderately Unsatisfactory	2008-06-26
Project Management	Unsatisfactory	2008-06-26
Financial Management	Unsatisfactory	2008-06-26
Monitoring and Evaluation	Unsatisfactory	2008-06-26

COMPLETION RATINGS

INDICATOR	IMPLEMENTATION COMPLETION & RESULTS REPORT: 12-30-2008
Outcomes	Substantial
Risk to Development Outcome	Modest
Bank Performance	Moderately Unsatisfactory
Borrower Performance	Moderately Unsatisfactory
Government Performance	Unsatisfactory
Implementing Agency	Moderately Satisfactory

INDEPENDENT EVALUATION RATINGS

INDICATOR	ICR REVIEW: 02-04-2011	PROJECT PERFORMANCE ASSESSMENT REPORT:
Outcome Rating	Moderately Unsatisfactory	N/a
Risk To Development Outcome	Moderate	N/a
Bank Performance	Moderately Unsatisfactory	N/a
Borrower Performance	Moderately Unsatisfactory	N/a
Government Performance	Moderately Unsatisfactory	N/a
Implementing Agency	Moderately Unsatisfactory	N/a
Icr Quality	Satisfactory	N/a
M&e Quality	Negligible	N/a

Results Framework